Table 3.
Prognosis of asymptomatic hemodialysis patients with preserved LVEF
| Less Negative GLS group (GLS ≥−15%, n=15) | More Negative GLS group (GLS <−15%, n=73) | P | |||
|---|---|---|---|---|---|
| Primary outcome | |||||
| All-cause mortality | 9 (60) | 15 (21) | 0.004 | ||
| Secondary outcomes | |||||
| Cardiovascular death | 4 (27) | 5 (7) | 0.04 | ||
| Revascularization | 1 (7) | 5 (7) | >0.99 | ||
| Admission due to heart failure | 2 (13) | 3 (4) | 0.20 | ||
| Admission due to angina pectoris | 4 (27) | 9 (12) | 0.22 | ||
| Major adverse cardiovascular eventa | 5 (33) | 9 (12) | 0.05 | ||
Data are presented as n (%). LVEF, left ventricular ejection fraction; GLS, global left ventricular peak systolic longitudinal strain.
a
Major adverse cardiovascular events include cardiovascular death, revascularization, and admission due to heart failure or angina.